TickerFacts.

A business in context

MIRM research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-16 · 0001974200-26-000014

  2. 4 · Ownership change

    Report date 2026-10-09 · 0002155916-26-000004

  3. 8-K · Current report

    Report date 2026-10-12 · 0001759425-26-000051 · Items 8.01

  4. 4 · Ownership change

    Report date 2026-10-06 · 0001614740-26-000014

  5. 8-K · Current report

    Report date 2026-09-25 · 0001759425-26-000049 · Items 8.01

  6. 4 · Ownership change

    Report date 2026-09-11 · 0001197350-26-000010

  7. 8-K · Current report

    Report date 2026-09-02 · 0001759425-26-000047 · Items 5.02

  8. 4 · Ownership change

    Report date 2026-09-02 · 0001974200-26-000013

  9. 4 · Ownership change

    Report date 2026-09-01 · 0001614740-26-000013

  10. 4 · Ownership change

    Report date 2026-08-18 · 0001974200-26-000012

  11. 4 · Ownership change

    Report date 2026-08-11 · 0001197350-26-000009

  12. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001759425-26-000045

  13. 8-K · Current report

    Report date 2026-08-05 · 0001759425-26-000044 · Items 2.02,9.01

  14. 8-K · Current report

    Report date 2026-06-15 · 0001193125-26-275811 · Items 5.07

  15. 8-K · Current report

    Report date 2026-05-12 · 0001193125-26-228902 · Items 1.01,2.03,3.02,8.01,9.01

  16. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001759425-26-000037

  17. 8-K · Current report

    Report date 2026-05-06 · 0001759425-26-000036 · Items 2.02,9.01

  18. 8-K · Current report

    Report date 2026-05-04 · 0001193125-26-202609 · Items 8.01

  19. 8-K · Current report

    Report date 2026-04-27 · 0001193125-26-179048 · Items 8.01

  20. DEF 14A · Proxy statement

    Report date 2025-12-31 · 0001759425-26-000027

  21. 8-K/A · Current report

    Report date 2026-01-23 · 0001759425-26-000021 · Items 9.01

  22. 10-K · Annual report

    Report date 2025-12-31 · 0001759425-26-000013

  23. 8-K · Current report

    Report date 2026-02-25 · 0001759425-26-000010 · Items 2.02,9.01

  24. 8-K · Current report

    Report date 2026-01-23 · 0001193125-26-022582 · Items 2.01,7.01,8.01,9.01

  25. 8-K · Current report

    Report date 2026-01-12 · 0001759425-26-000004 · Items 2.02,7.01,9.01

  26. 8-K · Current report

    Report date 2025-12-19 · 0001193125-25-326822 · Items 8.01

  27. 8-K · Current report

    Report date 2025-12-18 · 0001193125-25-325825 · Items 1.01,3.02,7.01,9.01

  28. 8-K · Current report

    Report date 2025-12-06 · 0001193125-25-310611 · Items 1.01,3.02,7.01,8.01,9.01

  29. 8-K · Current report

    Report date 2025-11-17 · 0001759425-25-000057 · Items 8.01

  30. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001759425-25-000054

  31. 8-K · Current report

    Report date 2025-11-04 · 0001759425-25-000053 · Items 2.02,9.01

  32. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001759425-25-000041

  33. 8-K · Current report

    Report date 2025-08-06 · 0001759425-25-000040 · Items 2.02,9.01

  34. 8-K · Current report

    Report date 2025-05-29 · 0001759425-25-000034 · Items 5.07

  35. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001759425-25-000032

  36. 8-K · Current report

    Report date 2025-05-07 · 0001759425-25-000030 · Items 2.02,9.01

  37. DEF 14A · Proxy statement

    Report date 2025-04-14 · 0001759425-25-000022

  38. 10-K · Annual report

    Report date 2024-12-31 · 0001759425-25-000014

  39. 8-K · Current report

    Report date 2025-02-26 · 0001759425-25-000012 · Items 2.02,9.01

  40. 8-K · Current report

    Report date 2025-01-13 · 0001759425-25-000003 · Items 2.02,7.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 19 transaction rows19SGrant / award: 0 transaction rows0AExercise / conversion: 10 transaction rows10MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

29 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-14
2026-09-15
BJERKHOLT ERICS · Sale
Disposed
Common Stock9943.098.37
2026-09-11
2026-09-15
BJERKHOLT ERICM · Exercise / conversion
Acquired
Common Stock18333.0n/a
2026-09-11
2026-09-15
BJERKHOLT ERICM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
18333.00.0
2026-09-02
2026-09-03
Howe Jolanda
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock658.0100.0
2026-09-01
2026-09-03
Peetz Christopher
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock8312.098.08
2026-09-01
2026-09-03
Peetz Christopher
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock30000.02.94
2026-09-01
2026-09-03
Peetz Christopher
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock21688.098.91
2026-09-01
2026-09-03
Peetz Christopher
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Stock Option (right to buy)
Derivative security
30000.00.0
2026-08-18
2026-08-19
Howe JolandaS · Sale
Disposed
Common Stock40000.0100.0
2026-08-18
2026-08-19
Howe JolandaM · Exercise / conversion
Acquired
Common Stock40000.06.27
2026-08-18
2026-08-19
Howe JolandaM · Exercise / conversion
Disposed
Employee Stock Option (right to buy)
Derivative security
40000.00.0
2026-08-11
2026-08-12
BJERKHOLT ERIC
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock6001.099.9
2026-08-10
2026-08-11
Peetz Christopher
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock6017.099.25
2026-08-10
2026-08-11
Peetz Christopher
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock20000.02.94
2026-08-10
2026-08-11
Peetz Christopher
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock11683.098.51
2026-08-10
2026-08-11
Peetz Christopher
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2300.0100.14
2026-08-10
2026-08-11
Peetz Christopher
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Stock Option (right to buy)
Derivative security
20000.00.0
2026-08-03
2026-08-05
Howe Jolanda
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1840.0105.29
2026-07-06
2026-07-08
Peetz Christopher
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock20000.02.94
2026-07-06
2026-07-08
Peetz Christopher
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock12134.0121.65
2026-07-06
2026-07-08
Peetz Christopher
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock4181.0122.34
2026-07-06
2026-07-08
Peetz Christopher
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1710.0124.79
2026-07-06
2026-07-08
Peetz Christopher
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1975.0123.74
2026-07-06
2026-07-08
Peetz Christopher
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Stock Option (right to buy)
Derivative security
20000.00.0
2026-07-06
2026-07-08
BJERKHOLT ERIC
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock300.0124.94
2026-07-06
2026-07-08
BJERKHOLT ERIC
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock528.0123.84
2026-07-06
2026-07-08
BJERKHOLT ERIC
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1048.0122.43
2026-07-06
2026-07-08
BJERKHOLT ERIC
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3124.0121.67
2026-07-01
2026-07-02
Howe Jolanda
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2721.0120.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001759425Mirum Pharmaceuticals, Inc.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
254900YZKR40F7F27K81
GLEIF legal name
MIRUM PHARMACEUTICALS, INC.
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2026-03-03T07:39:39Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Mirum Pharmaceuticals · alias · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$336.89M$361.85M
2023-12-31$186.37M$206.08M
2022-12-31$77.06M$88.71M
2021-12-31$19.14M$23.79M
2020-12-31$0$0

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗